{
    "clinical_study": {
        "@rank": "62194", 
        "acronym": "METODO", 
        "arm_group": {
            "arm_group_label": "pts addicted to heroin in MMT", 
            "description": "patients addicted to heroin who have undertaken methadone maintenance treatment"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study ( observational and prospective ) is to evaluate the efficacy and\n      tolerability  of the methadone maintenance treatment in patients addicted to heroin. The\n      efficacy and tolerability are assessed by correlating to the adequacy of the dosage of\n      methadone. The patients will be observed for two years."
        }, 
        "brief_title": "Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT.", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heroin Addiction", 
        "condition_browse": {
            "mesh_term": [
                "Heroin Dependence", 
                "Behavior, Addictive"
            ]
        }, 
        "detailed_description": {
            "textblock": "500 patients will be selected among all patients addicted to heroin according to DSM-IV_TR\n      (Diagnostic and Statistical Manual of Mental Disorders IV_ text revision), in maintenance\n      methadone treatment, observed in the involved sites. The investigators will use treatment\n      schemes with methadon conform to clinical practice and according to SPC (Summary of Product\n      Characteristics).\n\n      The enrollment will be competitive. Patients that meet incl/excl and that sign the informed\n      consent, will be observed for 2 years. Follow up visits will be performed according to\n      routine procedures, for patients that belong regularly to site at 3/6/9/12/18/24 months post\n      V1. During the visits, patients will be assessed by validated and used as clinical practice\n      questionnaires . For the evaluations of tolerability and safety the laboratory tests and\n      electrocardiograms routinely performed will be collected."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Both sexes\n\n          -  Over 18 years of age\n\n          -  Patients with a diagnosis of heroin addiction according to ICD-10 (International\n             Classification of Diseases)\n\n          -  Patients who have undertaken a methadone maintenance treatment\n\n          -  Adhesion to observational study by signing informed consent.\n\n        Exclusion Criteria:\n\n          -  Inability to follow the observation\n\n          -  Diagnosis of decompensated psychotic disorders"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients addicted to heroin and who have undertaken a methadone maintenance treatment,\n        observed in involved centres."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02062736", 
            "org_study_id": "M.E.T.O.D.O."
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Heroin", 
                "Methadone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "methadone", 
            "heroin addiction", 
            "methadone maintenance treatment", 
            "adequate dosage of methadone"
        ], 
        "lastchanged_date": "February 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "state": "BO", 
                        "zip": "40138"
                    }, 
                    "name": "Dipartimento DSM, DP area Dipendenze Patologiche, UOSD Ser.T BO est"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "state": "MI", 
                        "zip": "20063"
                    }, 
                    "name": "Dipartimento delle Dipendenze ASL MI 2"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pescara", 
                        "country": "Italy", 
                        "state": "PE", 
                        "zip": "65124"
                    }, 
                    "name": "Servizio dipendenze, AUSL"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "state": "TO", 
                        "zip": "10149"
                    }, 
                    "name": "Dipartimento Dipendenze, ASL TO 2"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00178"
                    }, 
                    "name": "U.O.C. Ser.T ASL RMC, Distretto 11"
                }
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Studio Osservazionale Per Valutare l'Adeguatezza Del Dosaggio Del Metadone, Nelle Terapie di Mantenimento, in Rapporto Agli Obbiettivi di Outcome, in Pazienti Tossicodipendenti da Eroina. (METODO)", 
        "overall_official": {
            "affiliation": "Solaris CRO", 
            "last_name": "Donatella Mariani", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "the efficacy of the methadone maintenance treatment in addicted heroin patients, evaluating the correlation among efficacy and adequate dosage in comparison to not adequate dosage.", 
            "safety_issue": "No", 
            "time_frame": "2 years ( 7 visits for patient )"
        }, 
        "reference": {
            "PMID": "23822738", 
            "citation": "D'Egidio PF, Bignamini E, De Vivo E, Leonardi C, Pieri MC, Gonz\u00e1lez-Saiz F, Lucchini A; METODO Study Team. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation. Subst Use Misuse. 2013 Dec;48(14):1530-40. doi: 10.3109/10826084.2013.800886. Epub 2013 Jul 3."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02062736"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "QT prolongation risk in patients addicted to heroin who have undertaken MMT", 
                "safety_issue": "Yes", 
                "time_frame": "2 years ( evaluation at t0, t0 +6/12/18/24 months)"
            }, 
            {
                "measure": "psychopathological status of observed patients in correlation with the adequate dosage in comparison to not adequate dosages", 
                "safety_issue": "Yes", 
                "time_frame": "2 years ( 7 visits for patient )"
            }, 
            {
                "measure": "pharmacoeconomic condition correlated with the adequate dosage in comparison to not adequate dosage.", 
                "safety_issue": "No", 
                "time_frame": "2 years ( 7 visits for patient )"
            }
        ], 
        "source": "L.Molteni & C. dei F.lli  Alitti-Soc. di Esercizio S.p.A.", 
        "sponsors": {
            "collaborator": {
                "agency": "Solaris CRO", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "L.Molteni & C. dei F.lli  Alitti-Soc. di Esercizio S.p.A.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}